“biotech” Archives

in
Entry Author Date Location
Nonprofit LifeNet Acquires Biotech With San Antonio Presence 11/04/16 Texas
Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine 11/04/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Californians Still Hate Trump, But More Uncertain About Drug Companies 11/03/16 National
San Antonio’s Fountainhead Raising Money to Back Up Biomed Incubator 11/03/16 Texas
Flatiron, Foundation Med Link Records of 20,000 Cancer Patients 11/03/16 New York
Elanco Leads $8.5M Investment in RTP’s AgTech Accelerator 11/02/16 Raleigh Durham
New York Institutions, VCs Team up to Build Drug Discovery “Bridge” 10/31/16 New York
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Unity Nabs $116M To Bring “Diseases of Aging” Drugs Into Human Trials 10/27/16 San Francisco
Despite Low Crop Prices, Corporate and VC Agtech Investments Soar 10/27/16 National
With Insider Help, Ra Pharma Upsizes IPO, Bags $92M 10/25/16 Boston
FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer 10/25/16 National
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
Eli Lilly Wins FDA Nod for New Soft Tissue Sarcoma Drug 10/20/16 Indiana
Fred Hutch Team Wants To Move Clean-Room Gene Therapy To Tabletop 10/20/16 Seattle
Roundup: J&J and AT&T Grow in Houston, Inspyr and Meshify Move On 10/19/16 Texas
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
The Power of the Cloud for Life Science R&D 10/19/16 Boston
CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul 10/18/16 Boston
Eli Lilly Commits $15M More to Seattle Institute’s TB Drug Search 10/18/16 Indiana
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Veritas Genetics Lands $30M for $1,000 Genome Sequencing 10/17/16 Boston
Last Chance to Save on Boston’s Life Science Disruptors on 10/20 10/17/16 Boston
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Aquaculture Industry Casts Wider Net in Food and Consumer Markets 10/13/16 Raleigh Durham
Startups Predict the Future for Free Tickets to Disruptors 2016 10/13/16 Texas
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Bay Area Researchers Take A CRISPR Cut At Sickle Cell Disease 10/12/16 San Francisco
Page 2 of 242 « previous page · next page »